CASESTOR
Live / Registered — Registered (as of 08 Aug 2023)
What this means for you
Registered since 08 Aug 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Aug 2029: the §8 declaration of use).
Record
- Serial number
- 97270466
- Registration number
- 7129985
- Mark type
- Word mark
- Filed
- 16 Feb 2022
- Published for opposition
- 23 May 2023
- Registered
- 08 Aug 2023
- Next maintenance filing
- §8 declaration of use, due by 08 Aug 2029 (grace period to 08 Feb 2030)
- Attorney of record
- Ethan J. Ung
Goods and services
- Class 005 — Pharmaceuticals: Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical or veterinary purposes, in particular, for biopreservation, cryostorage for cells and tissues, for use as components of biopharmaceuticals, and for general medical diagnostic use; medical diagnostic biochemical and biological reagents for use in detection or treatment, or other medical purposes
Owner
- Case Bioscience, North Redington Beach, FL, US
- Case Bioscience, North Redington Beach, FL, US
- Case Bioscience, North Redington Beach, FL, US
Prosecution history
- 26 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 May 2023 — PUBLISHED FOR OPPOSITION
- 03 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Mar 2023 — NON-FINAL ACTION E-MAILED
- 14 Mar 2023 — NON-FINAL ACTION WRITTEN